Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Sponsor

University of Alberta (Other)

Overall Status

Completed

CT.gov ID

NCT00175175

Collaborator

Alberta Heritage Foundation for Medical Research (Other), Royal Alexandra Hospital (Other)

220

Enrollment

Location

Study Details

Study Description

Brief Summary

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Condition or Disease	Intervention/Treatment	Phase
Osteoporosis Hip Fracture	Behavioral: Allied health professional-run osteoporosis service ("case-management")	N/A

Detailed Description

Study Design

Study Type:

Interventional

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single

Primary Purpose:

Treatment

Official Title:

Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Study Start Date :

Mar 1, 2002

Outcome Measures

Primary Outcome Measures

The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture []

Secondary Outcome Measures

Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months []
Proportion in receipt of a BMD test at 6 months and 12 months []
Proportion still adherent to osteoporosis treatments at 6 months and 12 months []
Proportion of patients with recurrent fractures at 6 months and 12 months []
Cost effectiveness analyses []

Eligibility Criteria

Criteria

Ages Eligible for Study:

50 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

hip fracture patient > 50 years of age
able to give consent (or proxy consent available)
lives within health region
no contraindications to bisphosphonate therapy

Exclusion Criteria:

refuses to participate or consent
dementia or delirium without a proxy consent available
nursing home or longterm care
pathologic fracture
chronic glucocorticoid use
already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)